-
Randomised trial comparing dopamine agonist, MAOB inhibitor and COMT inhibitor as adjuvant therapy in later Parkinson’s disease (PD)
-
Randomized controlled trial protocol: Balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease
-
Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease
-
Rasagiline treatment for sleep disorders in Parkinson’s disease (RaSPar) – Double-blinded, randomized, placebo-controlled, placebo run-in-phase, polysomnography clinical trial
-
RBD increase non-motor symptom in Parkinson’s disease
-
RE-024: A potential phosphopantothenate replacement therapy in 2 patients with pantothenate kinase-associated neurodegeneration (PKAN)
-
RE-024: Mechanism of action and efficacy in non-clinical models
-
Re-emergent tremor in Parkinson’s disease: Epidemiological and clinical features
-
Reach-to-grasp impairments of both hands in individuals with Parkinson’s disease
-
Real world conversion of levodopa to a novel extended release levodopa preparation: Determining predictors and dose ratios
-
Real-life data on the use of levodopa carbidopa intestinal gel in Parkinson’s disease
-
Real-time ultrasound for automated analysis and visualization of neck muscles in cervical dystonia
-
Real-world safety of deep brain stimulation in patients with ≤7.5 years between disease onset and device implant
-
Recent result of indicative evaluation for deep brain stimulation of Parkinson’s disease patients
-
Recharge frequency is not driven by therapy power usage in patients implanted with rechargeable deep brain stimulation systems
-
Rechargeable pacemaker technology in deep brain stimulation: A step forward, but nor for everyone
-
Recognition of parkinsonism in African Americans in a community-based sample
-
Recruitment of single subthalamic neurons for kinematic control of hand and feet movements employs different strategies
-
Reduced lifespan and climbing ability observed in the overexpressing human α-synuclein without heat shock protein CNB115 in Parkinson’s disease drosophila line
-
Reduced thalamo-cortical functional connectivity in asymptomatic LRRK2 mutation carriers
-
Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy
-
Reduction in battery longevity for each subsequent implantable pulse generator (IPG) in patients with Parkinson’s disease (PD) treated with bilateral subthalamic nucleus deep brain stimulation (STN-DBS) may be due to both programming changes and IPG model – a case series
-
Refined basal ganglia model accounting for GPi modulation of thalamic tonic and burst modes
-
Reflex saccades changes can estimate long-term symptom progression in DBS STN and MED Parkinson’s disease patients (PD)
-
Regional differences in the results of a phase 2b study of tozadenant in Parkinson’s disease patients with motor fluctuations
-
Regular exercise is associated with better two-year outcomes in Parkinson’s disease: National Parkinson foundation quality improvement initiative (NPF-QII) data
-
Regulation in speech motor control in ET patients treated with DBS: Kinematics of the lingual and the labial systems
-
Rehabilitation of dysphagia in Parkinson’s disease: Effect of chin-down postural maneuver
-
Relation between personality trait and depression in Parkinson’s disease
-
Relation between the clinical features and the standardized heart to mediastinum ratio in cardiac metaiodobenzylguanidine imaging in patients with Parkinson’s disease: A multicenter cross-sectional study
-
Relationship between Alzheimer’s disease GWAS-linked top hits and risk of Parkinson’s disease with or without cognitive decline: A Chinese population-based study
-
Relationship between balance, trunk impairment and hand function in Parkinson’s disease
-
Relationship between cognitive functions and striatal 123I-FP-CIT uptake in Parkinson’s disease
-
Relationship between fatigue and sleep disturbances in patients with Parkinson’s disease: A study using Parkinson’s disease sleep scale-2
-
Relationship between freezing and pedunculopontine nucleus’ size in Parkinson’s disease: Semi quantitative analysis based on MRI with modified FGATIR sequence
-
Relationship between sensory augmentation and exercise routine in the improvement in balance and gait in a patient with lithium-induced ataxia
-
Relationship between the MDS-UPDRS and quality of life in Parkinson’s disease: A large international multicenter study of 3206 patients (the QUALPD study)
-
Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease
-
Relationship of muscular strength with cardiovascular function in Parkinson’s disease
-
Relationship of serum ferritin level and tic severity in children with Tourette syndrome
-
Relationships of cognitive functions and psychiatric symptoms with motor phenotypes in patients with untreated early-stage Parkinson’s disease
-
Relative hypoglycemia induces acute chorea followed by chronic parkinsonism in a diabetic patient on hemodialysis: A case with sequential clinico-radiological correlate
-
Reliability and responsiveness of in-clinic and at-home app-based bradykinesia assessment
-
Reliability of a newly developed protocol for fiberoptic endoscopic evaluation of swallowing in Parkinson’s patients (PARK-FEES)
-
Reliability of the sensory organization test to predict falls in individuals with Parkinson’s disease
-
Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?
-
Repeat size and X-inactivation in the clinical phenotype of fragile X premutation carrier sisters: A familial case series
-
Research of vestibular evoked myogenic potentials (VEMP) in the diagnosis of postural instability in Parkinson’s disease
-
Resetting tremor by single pulse transcranial magnetic stimulation at the motor cortex and the cerebellum in essential tremor and dystonic tremor
-
Response inhibition in Parkinson’s disease
-
Response to thermal and pain stimulation and genetic variance for pain in patients with Parkinson’s disease – Are they all related?
-
Resting state functional connectivity in olfactory network in de novo Parkinson’s disease
-
Resting-state functional connectivity of subthalamic nucleus in different phenotypes of Parkinson’s disease
-
Results from a double-blind trial of pallidal DBS for Tourette’s syndrome: Are there any predictors of surgery outcome?
-
Results of the German registry of pediatric deep brain stimulation in patients with childhood-onset dyskinetic movement disorders (GEPESTIM)
-
Retinal nerve fiber layer thinning: A window into rapid eye movement sleep behavior disorders in Parkinson’s disease
-
Retrieval action verbs is impaired in Parkinson´s disease patients using a sentence completion task
-
Reward insensitivity differentiates apathy from depression in Parkinson’s disease
-
Risk factors associated with postural changes in Parkinson’s disease
-
Risk factors for premature withdraw from the LS-1 PD study
-
Risk factors of wearing-off phenomenon in Parkinson’s disease in Japan
-
Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders
-
Risk prediction modeling in Parkinson’s disease using genetic and environmental/lifestyle factors
-
Risks and predictive factors for pneumonia amongst Parkinson’s disease patients with dysphagia
-
Robust sensorimotor deficits in a knock-in mouse model of primary torsion dystonia
-
Role of contact polarity on therapeutic impedances at two deep brain stimulation (DBS) targets
-
Role of dopamine and GABA during subthalamic and pallidal deep brain stimulation: Evidence of dopamine release during subthalamic Deep Brain Stimulation
-
Role of macroautophagy in regulating microglia-mediated neuroinflammation and dopaminergic neuron injury
-
Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia
-
Role of the nurse coordinator within a unit for treatment of neuro-surgical behaviours and abnormal movements
-
Roles of combined functional catechol-o-methyltransferase genotypes in Chinese Parkinson’s disease: A cross-sectional survey
-
Rotenone and Parkinson’s disease (PD): Effect modification by membrane transporter variants
-
Rotigotine transdermal patch in Chinese patients with advanced Parkinson’s disease: A randomized, double-blind study
2016 International Congress
June 19-23, 2016. Berlin, Germany.